Published in J Ethnopharmacol on July 03, 2012
Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design. Proc Natl Acad Sci U S A (2013) 1.07
Therapeutic effects of date fruits (Phoenix dactylifera) in the prevention of diseases via modulation of anti-inflammatory, anti-oxidant and anti-tumour activity. Int J Clin Exp Med (2014) 0.97
Herbal medicine use and linked suspected adverse drug reactions in a prospective cohort of Ugandan inpatients. BMC Complement Altern Med (2016) 0.76
An exploration of village-level uterotonic practices in Fenerive-Est, Madagascar. BMC Pregnancy Childbirth (2016) 0.75
The African Pitocin - a midwife's dilemma: the perception of women on the use of herbs in pregnancy and labour in Zimbabwe, Gweru. Pan Afr Med J (2016) 0.75
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69
Natural products in drug discovery and development. J Nat Prod (1997) 4.94
Telomerase immortalization of human myometrial cells. Biol Reprod (2002) 1.48
Ethnobotanical survey of anti-asthmatic plants in South Western Nigeria. Afr J Tradit Complement Altern Med (2008) 1.22
Community mobilization to reduce postpartum hemorrhage in home births in northern Nigeria. Soc Sci Med (2012) 1.19
Uterotonic plants and their bioactive constituents. Planta Med (2010) 1.04
Uterine contraction induced by Tanzanian plants used to induce abortion. J Ethnopharmacol (2011) 1.04
Modulation of human uterine smooth muscle cell collagen contractility by thrombin, Y-27632, TNF alpha and indomethacin. Reprod Biol Endocrinol (2009) 1.03
Use of medicinal plants for the treatment of measles in Nigeria. J Ethnopharmacol (2009) 1.03
Ethnobotanical study of the medicinal plants from Tlanchinol, Hidalgo, México. J Ethnopharmacol (2008) 0.99
From the field into the lab: useful approaches to selecting species based on local knowledge. Front Pharmacol (2011) 0.94
Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol (2010) 0.84
Desensitisation of the oxytocin receptor and other G-protein coupled receptors in the human myometrium. Exp Physiol (2001) 0.83
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology (2009) 2.44
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev (2003) 2.23
Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab (2009) 2.10
Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol (2003) 1.75
Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol (2003) 1.51
Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol (2008) 1.45
Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes. Eur J Immunol (2002) 1.36
Improved detection of DNA motifs using a self-organized clustering of familial binding profiles. Bioinformatics (2005) 1.29
Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol (2002) 1.26
Isolation and phenotypic characterization of lung fibroblasts. Methods Mol Med (2005) 1.24
Integrated microfluidic tmRNA purification and real-time NASBA device for molecular diagnostics. Lab Chip (2008) 1.22
More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest (2006) 1.21
Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J Immunol (2007) 1.20
The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J Biol Chem (2012) 1.19
IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. J Immunol (2005) 1.18
Defining linkages between the GSC and NSF's LTER program: how the Ecological Metadata Language (EML) relates to GCDML and other outcomes. OMICS (2008) 1.15
Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol (2002) 1.14
Immunopathogenesis of thyroid eye disease: emerging paradigms. Surv Ophthalmol (2010) 1.11
Transcription factor binding site identification using the self-organizing map. Bioinformatics (2005) 1.11
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci (2008) 1.10
Cyclotide discovery in Gentianales revisited-identification and characterization of cyclic cystine-knot peptides and their phylogenetic distribution in Rubiaceae plants. Biopolymers (2013) 1.10
Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production. J Clin Endocrinol Metab (2012) 1.08
Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design. Proc Natl Acad Sci U S A (2013) 1.07
Immune mechanisms in thyroid eye disease. Thyroid (2008) 1.05
Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab. Clin Endocrinol (Oxf) (2011) 1.04
Inhibitory effect of leptin on human uterine contractility in vitro. Am J Obstet Gynecol (2006) 1.04
Uterotonic plants and their bioactive constituents. Planta Med (2010) 1.04
Modulation of human uterine smooth muscle cell collagen contractility by thrombin, Y-27632, TNF alpha and indomethacin. Reprod Biol Endocrinol (2009) 1.03
Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci (2014) 1.03
Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid (2008) 0.99
Insights into the molecular evolution of oxytocin receptor ligand binding. Biochem Soc Trans (2013) 0.99
Complex single gene disorders and epilepsy. Epilepsia (2012) 0.98
Characterizing circular peptides in mixtures: sequence fragment assembly of cyclotides from a violet plant by MALDI-TOF/TOF mass spectrometry. Amino Acids (2012) 0.98
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis. ACS Chem Biol (2013) 0.97
Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. Proc Natl Acad Sci U S A (2012) 0.97
B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. J Immunol (2008) 0.96
Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor. J Immunol (2004) 0.96
Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor. J Biol Chem (2013) 0.96
Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines. J Biol Chem (2006) 0.95
Treating the thyroid in the presence of Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab (2012) 0.94
Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. Invest Ophthalmol Vis Sci (2012) 0.94
Robust induction of PGHS-2 by IL-1 in orbital fibroblasts results from low levels of IL-1 receptor antagonist expression. Am J Physiol Cell Physiol (2003) 0.94
Do plant cyclotides have potential as immunosuppressant peptides? J Nat Prod (2012) 0.94
PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy. PLoS One (2010) 0.93
Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA. J Endocrinol (2011) 0.93
Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions. PLoS One (2013) 0.92
Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease. J Biol Chem (2011) 0.91
Formation of cyclotides and variations in cyclotide expression in Oldenlandia affinis suspension cultures. Appl Microbiol Biotechnol (2007) 0.90
Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab (2014) 0.90
Evaluation of human endothelial cells post stent deployment in a cardiovascular simulator in vitro. Ann Biomed Eng (2009) 0.90
Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology (2006) 0.88
Rosiglitazone-induced proptosis. Arch Ophthalmol (2005) 0.88
Analysis of Maxi-K alpha subunit splice variants in human myometrium. Reprod Biol Endocrinol (2004) 0.88
Microtubule-associated kinase-like protein RUNKEL needed [corrected] for cell plate expansion in Arabidopsis cytokinesis. Curr Biol (2009) 0.87
Rho A/Rho kinase mRNA and protein levels in human myometrium during pregnancy and labor. J Soc Gynecol Investig (2005) 0.87
Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism. PLoS One (2013) 0.87
Long-term exposure of CdTe quantum dots on PC12 cellular activity and the determination of optimum non-toxic concentrations for biological use. J Nanobiotechnology (2010) 0.87
Expression of prothrombin and protease activated receptors in human myometrium during pregnancy and labor. Biol Reprod (2007) 0.87
Molecular cloning of an IL-8-like CXC chemokine and tissue factor in rainbow trout (Oncorhynchus mykiss) by use of suppression subtractive hybridization. Cytokine (2002) 0.86
Cyclotide proteins and precursors from the genus Gloeospermum: filling a blank spot in the cyclotide map of Violaceae. Phytochemistry (2009) 0.86
Human chorionic gonadotrophin relaxation of human pregnant myometrium and activation of the BKCa channel. J Clin Endocrinol Metab (2003) 0.86
Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma. J Immunol (2005) 0.86
Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes. J Clin Endocrinol Metab (2005) 0.86
Acute phase gene expression in rainbow trout (Oncorhynchus mykiss) after exposure to a confinement stressor: A comparison of pooled and individual data. Fish Shellfish Immunol (2009) 0.85
Biologic therapeutics in thyroid-associated ophthalmopathy: translating disease mechanism into therapy. Thyroid (2008) 0.85
Testes and brain gene expression in precocious male and adult maturing Atlantic salmon (Salmo salar). BMC Genomics (2010) 0.85
Divergent expression of IL-1 receptor antagonists in CD34⁺ fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation. J Clin Endocrinol Metab (2013) 0.85
Upregulation of PSCDBP, TLR2, TWIST1, FLJ35382, EDNRB, and RGS12 gene expression in human myometrium at labor. Reprod Sci (2008) 0.84
Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE. J Clin Endocrinol Metab (2014) 0.84
Characterization of the anaemia associated with Graves' disease. Clin Endocrinol (Oxf) (2008) 0.84
CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver. Cancer Immunol Immunother (2006) 0.83
Pharmacotherapy: does selenium supplementation improve Graves ophthalmopathy? Nat Rev Endocrinol (2011) 0.83
tmRNA--a novel high-copy-number RNA diagnostic target--its application for Staphylococcus aureus detection using real-time NASBA. FEMS Microbiol Lett (2009) 0.83
Isolation and characterization of the bovine Stearoyl-CoAdesaturase promoter and analysis of polymorphisms in the promoter region in dairy cows. Mamm Genome (2005) 0.83
Differential expression of the metalloproteinase MMP3 and the alpha5 integrin subunit in human myometrium at labour. Mol Hum Reprod (2007) 0.83
Gene prediction using the Self-Organizing Map: automatic generation of multiple gene models. BMC Bioinformatics (2004) 0.82
Expression of RHOGTPase regulators in human myometrium. Reprod Biol Endocrinol (2008) 0.82
Is IGF-I receptor a target for autoantibody generation in Graves' disease? J Clin Endocrinol Metab (2013) 0.82
Cloning and characterization of two genes encoding rainbow trout homologues of the IFITM protein family. Vet Immunol Immunopathol (2006) 0.82
B cell depletion in Graves' disease: the right answer to the wrong question? J Clin Endocrinol Metab (2007) 0.82
Rapid detection of Listeria monocytogenes in food using culture enrichment combined with real-time PCR. Food Microbiol (2008) 0.82
Self-organizing neural networks to support the discovery of DNA-binding motifs. Neural Netw (2006) 0.81
Human fibrocytes express multiple antigens associated with autoimmune endocrine diseases. J Clin Endocrinol Metab (2014) 0.81
Liver immunity and tumour surveillance. Immunol Lett (2006) 0.81
Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy. Curr Opin Endocrinol Diabetes Obes (2008) 0.81
Good partner, good parent: responsiveness mediates the link between romantic attachment and parenting style. Pers Soc Psychol Bull (2012) 0.81
Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17. PLoS One (2012) 0.81
Hyaluronan accumulation in thyroid tissue: evidence for contributions from epithelial cells and fibroblasts. Endocrinology (2006) 0.81
Reengineering the collision coupling and diffusion mode of the A2A-adenosine receptor: palmitoylation in helix 8 relieves confinement. J Biol Chem (2012) 0.81